Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| North America (Primary) | PRIMARYNOAM | Univ | 8,145 | 59,660,955 | 0.15% | 1.60% | 6.01% | 6.51% | 16.95% | 26.43% |
| Healthcare | HEALTHCARE | Sector | 1,333 | 6,612,544 | 0.02% | 1.84% | 6.01% | 1.11% | 14.01% | 14.79% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 675 | 3,052,063 | -0.14% | 2.02% | 4.26% | -1.18% | 23.58% | 30.63% |
| Non-System-Specific Biopharmaceuticals | BIOPHARMANONSYS | Industry | 254 | 341,049 | -0.61% | 2.71% | 4.23% | -3.26% | 1.06% | -13.34% |
| Oncology Biopharmaceuticals | ONCOLOGY | SubInd | 195 | 182,107 | -0.85% | -0.72% | -2.34% | -8.26% | 6.15% | -6.03% |
Show Stocks
Sort: 1Mo %
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Y-mAbs Therapeutics, Inc. | YMAB:USAYMAB:USA | Stock | 1 | 509 | -2.11% | -5.54% | -22.67% | -29.91% | 120.11% | 12.19% |
| Immunome, Inc. | IMNM:USAIMNM:USA | Stock | 1 | 826 | -3.96% | -10.77% | -19.50% | -39.87% | 74.40% | 154.23% |
| CG Oncology, Inc. | CGON:USACGON:USA | Stock | 1 | 1,998 | -3.20% | 5.19% | -15.12% | -32.43% | N/A | N/A |
| Iovance Biotherapeutics, Inc. | IOVA:USAIOVA:USA | Stock | 1 | 2,865 | -1.82% | -6.61% | -12.63% | -14.88% | 132.73% | 37.63% |
| ALX Oncology Holdings, Inc. | ALXO:USAALXO:USA | Stock | 1 | 714 | -3.07% | -12.34% | -9.72% | -12.55% | 59.13% | 136.44% |
| Bristol Myers Squibb Co. | BMY:USABMY:USA | Stock | 1 | 89,249 | -0.18% | -2.02% | -8.84% | -10.67% | -11.37% | -30.11% |
| Northwest Biotherapeutics, Inc. | NWBO:USANWBO:USA | Stock | 1 | 556 | -3.02% | -4.61% | -8.73% | -23.37% | -44.91% | -19.80% |
| Exelixis, Inc. | EXEL:USAEXEL:USA | Stock | 1 | 6,169 | -1.51% | -2.15% | -7.03% | 1.36% | -0.33% | 5.98% |
| Arvinas, Inc. | ARVN:USAARVN:USA | Stock | 1 | 2,232 | 1.78% | 3.94% | -4.70% | -35.42% | 57.12% | 45.44% |
| Zentalis Pharmaceuticals, Inc. | ZNTL:USAZNTL:USA | Stock | 1 | 857 | 0.92% | -3.75% | -3.75% | -12.66% | 7.58% | -54.78% |
| Oric Pharmaceuticals, Inc. | ORIC:USAORIC:USA | Stock | 1 | 618 | 1.55% | 1.89% | -3.68% | -12.60% | 39.85% | 84.68% |
| Janux Therapeutics, Inc. | JANX:USAJANX:USA | Stock | 1 | 2,442 | -0.86% | -3.72% | -3.58% | 372.89% | 434.01% | 273.81% |
| OmniAb, Inc. | OABI:USAOABI:USA | Stock | 1 | 522 | -2.20% | -4.91% | -3.05% | -19.68% | 0.00% | 13.52% |
| Oncology Biopharmaceuticals | ONCOLOGY | SubInd | 195 | 182,107 | -0.85% | -0.72% | -2.34% | -8.26% | 6.15% | -6.03% |
| Arcellx, Inc. | ACLX:USAACLX:USA | Stock | 1 | 2,857 | 1.57% | 7.80% | -1.61% | -10.51% | 2.78% | 30.15% |
| Syndax Pharmaceuticals, Inc. | SNDX:USASNDX:USA | Stock | 1 | 1,724 | -3.01% | -6.71% | -0.98% | -11.28% | 37.00% | -4.52% |
| Olema Pharmaceuticals, Inc. | OLMA:USAOLMA:USA | Stock | 1 | 550 | 1.86% | 5.58% | -0.61% | -31.38% | -41.36% | 46.87% |
| Fusion Pharmaceuticals, Inc. | FUSN:USAFUSN:USA | Stock | 1 | 1,825 | 0.23% | 0.14% | 1.22% | 59.81% | 437.75% | 406.12% |
| Celcuity, Inc. | CELC:USACELC:USA | Stock | 1 | 516 | -5.10% | -0.42% | 2.26% | 16.39% | 37.04% | 69.04% |
| Day One Biopharmaceuticals, Inc. | DAWN:USADAWN:USA | Stock | 1 | 1,413 | 0.87% | 1.06% | 2.67% | 8.60% | 37.97% | 23.62% |
| Zymeworks, Inc. | ZYME:USAZYME:USA | Stock | 1 | 650 | -2.77% | 3.52% | 5.19% | -24.25% | 17.22% | -4.90% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,703 | 77,878,209 | 0.14% | 1.65% | 5.99% | 6.91% | 18.44% | 28.12% |
| Immatics NV | IMTX:USAIMTX:USA | Stock | 1 | 1,129 | 1.39% | 1.20% | 6.82% | -3.61% | 28.94% | 13.22% |
| Cargo Therapeutics, Inc. | CRGX:USACRGX:USA | Stock | 1 | 804 | -4.31% | 6.97% | 6.91% | -12.96% | 38.53% | N/A |
| IDEAYA Biosciences, Inc. | IDYA:USAIDYA:USA | Stock | 1 | 3,028 | -2.48% | -1.63% | 7.66% | -7.98% | 35.27% | 91.13% |
| Merus NV | MRUS:USAMRUS:USA | Stock | 1 | 2,577 | -2.47% | -1.37% | 8.50% | -2.23% | 84.50% | 100.69% |
| Relay Therapeutics, Inc. | RLAY:USARLAY:USA | Stock | 1 | 878 | 2.00% | 3.43% | 8.67% | -38.00% | -17.62% | -34.77% |
| Revolution Medicines, Inc. | RVMD:USARVMD:USA | Stock | 1 | 6,499 | 1.08% | 5.80% | 9.99% | 35.10% | 85.46% | 55.28% |
| Nuvalent, Inc. | NUVL:USANUVL:USA | Stock | 1 | 4,571 | -2.42% | 8.25% | 12.40% | -13.55% | 22.14% | 82.12% |
| Cogent Biosciences, Inc. | COGT:USACOGT:USA | Stock | 1 | 711 | -0.40% | -1.59% | 12.56% | -13.39% | 0.81% | -30.98% |
| Arcus Biosciences, Inc. | RCUS:USARCUS:USA | Stock | 1 | 1,536 | -3.21% | 1.14% | 13.88% | 1.81% | 20.28% | -4.03% |
| Lyell Immunopharma, Inc. | LYEL:USALYEL:USA | Stock | 1 | 698 | -1.44% | 11.38% | 17.60% | 29.25% | 46.52% | 8.73% |
| Halozyme Therapeutics, Inc. | HALO:USAHALO:USA | Stock | 1 | 5,686 | -1.50% | 3.62% | 18.25% | 24.19% | 13.13% | 34.26% |
| BridgeBio Pharma, Inc. | BBIO:USABBIO:USA | Stock | 1 | 5,631 | -3.06% | 3.40% | 20.60% | -16.30% | 4.26% | 115.24% |
| Xencor, Inc. | XNCR:USAXNCR:USA | Stock | 1 | 1,419 | 2.54% | 2.45% | 21.53% | -2.00% | 24.22% | -11.59% |
| Tyra Biosciences, Inc. | TYRA:USATYRA:USA | Stock | 1 | 958 | -4.40% | 5.24% | 24.56% | -3.03% | 55.40% | 37.60% |
| Kura Oncology, Inc. | KURA:USAKURA:USA | Stock | 1 | 1,689 | -3.52% | 7.05% | 25.40% | 9.32% | 143.89% | 79.95% |
| AnaptysBio, Inc. | ANAB:USAANAB:USA | Stock | 1 | 685 | -1.57% | 7.09% | 26.42% | 5.20% | 75.81% | 32.44% |
| Summit Therapeutics, Inc. | SMMT:USASMMT:USA | Stock | 1 | 3,117 | -1.55% | -4.52% | 26.50% | 18.72% | 138.71% | 174.07% |
| Cullinan Therapeutics, Inc. | CGEM:USACGEM:USA | Stock | 1 | 998 | -2.69% | -12.80% | 28.29% | 33.16% | 158.31% | 163.30% |
| Nuvation Bio, Inc. | NUVB:USANUVB:USA | Stock | 1 | 727 | -2.64% | 2.15% | 28.68% | 86.52% | 153.44% | 107.50% |
| Arrivent BioPharma, Inc. | AVBP:USAAVBP:USA | Stock | 1 | 673 | -0.25% | 13.56% | 29.68% | -2.57% | N/A | N/A |
| Enliven Therapeutics, Inc. | ELVN:USAELVN:USA | Stock | 1 | 1,078 | -3.23% | -1.66% | 30.39% | 39.05% | 121.11% | 14.86% |
| iTeos Therapeutics, Inc. | ITOS:USAITOS:USA | Stock | 1 | 647 | 0.84% | 3.50% | 74.73% | 75.58% | 84.37% | 22.87% |
| Deciphera Pharmaceuticals, Inc. | DCPH:USADCPH:USA | Stock | 1 | 2,092 | 0.04% | 0.39% | 78.92% | 63.73% | 107.84% | 83.30% |
* Colors indicate performance relative to the benchmark.